Crossmark

Drug pricing for hepatitis B and C in Australia and Japan

Crossref DOI link: https://doi.org/10.1016/j.aohep.2025.102118

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Suoh, Maito https://orcid.org/0000-0002-7505-9459
Esmaili, Saeed https://orcid.org/0000-0002-2843-7277
Eslam, Mohammed

George, Jacob
Funding

Funding for this research was provided by:

National Health and Medical Research Council (APP1107178, APP2001692, APP1053206, APP1196492, APP1108422)

University of Sydney

Cancer Institute NSW
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-09-08
More Information

This article is maintained by: Elsevier

Article Title: Drug pricing for hepatitis B and C in Australia and Japan

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2025.102118

Content Type: simple-article

Copyright: © 2025 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.